Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer is a research paper published in Frontiers in Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Commission
Grant: 273739
Context-Aware Recommender Systems (CARS)
National Institutes of Health
Grant: 5R21CA273739-02
Drug combination nanoparticles for advanced treatment of metastatic TNBC
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals